{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:47:17Z","timestamp":1792079237859,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s12010-026-05878-5","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T05:19:29Z","timestamp":1786943969000},"page":"8979-8995","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Span60\/Cholesterol Niosomal Formulation as a Transport Vehicle for L-DOPA and Rasagiline Delivery with Potent In Vitro Neuroprotective Effect"],"prefix":"10.1007","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1412-8411","authenticated-orcid":false,"given":"\u00d6zge","family":"\u00c7A\u011eLAR YILDIRIM","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7046-8990","authenticated-orcid":false,"given":"Hasan","family":"T\u00dcRKEZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"5878_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cger.2019.08.002","author":"DK Simon","year":"2020","unstructured":"Simon, D. K., Tanner, C. M., & Brundin, P. (2020). Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clinics in Geriatric Medicine, 36(1), 1-12. https:\/\/doi.org\/10.1016\/j.cger.2019.08.002","journal-title":"Clinics in Geriatric Medicine"},{"key":"5878_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13691","author":"S Sveinbjornsdottir","year":"2016","unstructured":"Sveinbjornsdottir, S. (2016). The clinical symptoms of Parkinson\u2019s disease. Journal of Neurochemistry, 139, 318-324. https:\/\/doi.org\/10.1111\/jnc.13691","journal-title":"Journal of Neurochemistry"},{"key":"5878_CR3","doi-asserted-by":"publisher","DOI":"10.4314\/tjpr.v8i3.44546","author":"NA Ochekpe","year":"2009","unstructured":"Ochekpe, N. A., Olorunfemi, P. O., & Ngwuluka, N. C. (2009). Nanotechnology and drug delivery part 1: Background and applications. Tropical Journal of Pharmaceutical Research, 8(3). https:\/\/doi.org\/10.4314\/tjpr.v8i3.44546","journal-title":"Tropical Journal of Pharmaceutical Research"},{"key":"5878_CR4","doi-asserted-by":"publisher","DOI":"10.22038\/IJBMS.2022.61687.13650","author":"MES El-Shamarka","year":"2022","unstructured":"El-Shamarka, M. E. S., Abdel-Salam, O. M. E., Shafee, N., & Zeidan, H. M. (2022). Curcumin modulation of L-dopa and rasagiline-induced neuroprotection in rotenone model of Parkinson\u2019s disease. Iranian Journal of Basic Medical Sciences, 26(2), 139. https:\/\/doi.org\/10.22038\/IJBMS.2022.61687.13650","journal-title":"Iranian Journal of Basic Medical Sciences"},{"key":"5878_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121878","author":"S Yasamineh","year":"2022","unstructured":"Yasamineh, S., Yasamineh, P., Kalajahi, G., Gholizadeh, H., Yekanipour, O., Afkhami, Z., & Dadashpour, H., M (2022). A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system. International Journal of Pharmaceutics, 624, 121878. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121878","journal-title":"International Journal of Pharmaceutics"},{"key":"5878_CR6","doi-asserted-by":"publisher","DOI":"10.1039\/d0nr04037a","author":"EA Burilova","year":"2020","unstructured":"Burilova, E. A., Pashirova, T. N., Zueva, I. V., Gibadullina, E. M., Lushchekina, S. V., Sapunova, A. S., & Sinyashin, O. G. (2020). Bi-functional sterically hindered phenol lipid-based delivery systems as potential multi-target agents against Alzheimer\u2019s disease: Via an intranasal route. Nanoscale, 12(25), 13757-13770. https:\/\/doi.org\/10.1039\/d0nr04037a","journal-title":"Nanoscale"},{"key":"5878_CR7","doi-asserted-by":"publisher","DOI":"10.53730\/ijhs.v6ns6.11391","author":"S Agrawal","year":"2022","unstructured":"Agrawal, S., & Jain, P. (2022). Formulation, evaluation, and in vitro drug diffusion of niosomal gel of selected drug. International journal of health sciences, 6(S6), 7338\u20137351. https:\/\/doi.org\/10.53730\/ijhs.v6ns6.11391","journal-title":"International journal of health sciences"},{"key":"5878_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101945","author":"AS Nayak","year":"2020","unstructured":"Nayak, A. S., Chodisetti, S., Gadag, S., Nayak, U. Y., Govindan, S., & Raval, K. (2020). Tailoring solulan C24 based niosomes for transdermal delivery of donepezil: In vitro characterization, evaluation of pH sensitivity, and microneedle-assisted Ex vivo permeation studies. Journal of Drug Delivery Science and Technology, 60, 101945. https:\/\/doi.org\/10.1016\/j.jddst.2020.101945","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"5878_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.matpr.2021.09.010","author":"MK Faheela","year":"2022","unstructured":"Faheela, M. K., Malathi, S., Monica Susai Mary, S., & Narayana Kalkura, S. (2022). In-vitro characterization of pluronic P 123 based niosome for targeted delivery of doxorubicin. Materials Today: Proceedings, 58, 795-801. https:\/\/doi.org\/10.1016\/j.matpr.2021.09.010","journal-title":"Materials Today: Proceedings"},{"key":"5878_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/00207454.2020.1754211","author":"ME Arslan","year":"2021","unstructured":"Arslan, M. E., T\u00fcrkez, H., & Mardino\u011flu, A. (2021). In vitro neuroprotective effects of farnesene sesquiterpene on Alzheimer\u2019s disease model of differentiated neuroblastoma cell line. International Journal of Neuroscience, 131(8):745-754. https:\/\/doi.org\/10.1080\/00207454.2020.1754211","journal-title":"International Journal of Neuroscience"},{"issue":"2","key":"5878_CR11","doi-asserted-by":"publisher","first-page":"570","DOI":"10.26355\/eurrev_202301_31058","volume":"27","author":"ME Arslan","year":"2023","unstructured":"Arslan, M. E., & Yilmaz, A. (2023). Neuroprotective effects of Geranium Robertianum L. Aqueous extract on the cellular Parkinson\u2019s disease model. European Review for Medical and Pharmacological Sciences, 27(2), 570\u2013579. https:\/\/doi.org\/10.26355\/eurrev_202301_31058","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"5878_CR12","doi-asserted-by":"publisher","unstructured":"Schmittgen, T. D., & Livak, K. J. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25(4):402-408. https:\/\/doi.org\/10.1006\/meth.2001.1262","DOI":"10.1006\/meth.2001.1262"},{"key":"5878_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-02073-w","author":"R Naderi","year":"2021","unstructured":"Naderi, R., Pardakhty, A., Abbasi, M. F., Ranjbar, M., & Iranpour, M. (2021). Preparation and evaluation of crocin loaded in nanoniosomes and their effects on ischemia\u2013reperfusion injuries in rat kidney. Scientific Reports, 11(1), 23525. https:\/\/doi.org\/10.1038\/s41598-021-02073-w","journal-title":"Scientific Reports"},{"key":"5878_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.05.044","author":"C Saraiva","year":"2016","unstructured":"Saraiva, C., Pra\u00e7a, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016). Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. Journal of Controlled Release, 235, 34-47. https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.044","journal-title":"Journal of Controlled Release"},{"issue":"3","key":"5878_CR15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.surneu.2003.09.036","volume":"61","author":"GA Silva","year":"2004","unstructured":"Silva, G. A. (2004). Introduction to nanotechnology and its applications to medicine. Surgical Neurology, 61(3), 216\u2013220. https:\/\/doi.org\/10.1016\/j.surneu.2003.09.036","journal-title":"Surgical Neurology"},{"key":"5878_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2005.03.003","author":"L Yang","year":"2005","unstructured":"Yang, L., & Watts, D. J. (2005). Particle surface characteristics may play an important role in phytotoxicity of alumina nanoparticles. Toxicology Letters, 158(2), 122-132. https:\/\/doi.org\/10.1016\/j.toxlet.2005.03.003","journal-title":"Toxicology Letters"},{"key":"5878_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/nano11061573","author":"M Moghtaderi","year":"2021","unstructured":"Moghtaderi, M., Mirzaie, A., Zabet, N., Moammeri, A., Mansoori-Kermani, A., & Akbarzadeh, I.\u2026 Ren, Q. (2021). Enhanced antibacterial activity of echinacea angustifolia extract against multidrug-resistant klebsiella pneumoniae through niosome encapsulation. Nanomaterials, 11(6), 1573. https:\/\/doi.org\/10.3390\/nano11061573","journal-title":"Nanomaterials"},{"key":"5878_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-020-00715-6","author":"A Farmoudeh","year":"2020","unstructured":"Farmoudeh, A., Akbari, J., Saeedi, M., Ghasemi, M., Asemi, N., & Nokhodchi, A. (2020). Methylene blue-loaded niosome: Preparation, physicochemical characterization, and in vivo wound healing assessment. Drug Delivery and Translational Research, 10(5), 1428-1441. https:\/\/doi.org\/10.1007\/s13346-020-00715-6","journal-title":"Drug Delivery and Translational Research"},{"key":"5878_CR19","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.34.945","author":"R Rajera","year":"2011","unstructured":"Rajera, R., Nagpal, K., Singh, S. K., & Mishra, D. N. (2011). Niosomes: A controlled and novel drug delivery system. Biological and Pharmaceutical Bulletin, 34(7), 945-953. https:\/\/doi.org\/10.1248\/bpb.34.945","journal-title":"Biological and Pharmaceutical Bulletin"},{"key":"5878_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2019.05.015","author":"M Rezvani","year":"2019","unstructured":"Rezvani, M., Hesari, J., Peighambardoust, S. H., Manconi, M., Hamishehkar, H., & Escribano-Ferrer, E. (2019). Potential application of nanovesicles (niosomes and liposomes)for fortification of functional beverages with Isoleucine-Proline-Proline: A comparative study with central composite design approach. Food Chemistry, 30(293), 368-377. https:\/\/doi.org\/10.1016\/j.foodchem.2019.05.015","journal-title":"Food Chemistry"},{"key":"5878_CR21","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2011.573784","author":"S Perez-Lloret","year":"2011","unstructured":"Perez-Lloret, S., & Rascol, O. (2011). Safety of rasagiline for the treatment of Parkinson\u2019s disease. Expert Opinion on Drug Safety, 10(4), 633-643. https:\/\/doi.org\/10.1517\/14740338.2011.573784","journal-title":"Expert Opinion on Drug Safety"},{"key":"5878_CR22","doi-asserted-by":"publisher","unstructured":"Sarkar, B., Roy, S. D., & Shil, D. (2025). Nanogels as next-generation drug delivery systems: Design, advances, and biomedical applications. Journal of Biological Methods, 13(1), e99010090. https:\/\/doi.org\/10.14440\/jbm.0239","DOI":"10.14440\/jbm.0239"},{"key":"5878_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600501018","author":"T Higuchi","year":"1961","unstructured":"Higuchi, T. (1961). Rate of release of medicaments from ointment bases containing drugs in suspension. Journal of Pharmaceutical Sciences, 50(10),874-875. https:\/\/doi.org\/10.1002\/jps.2600501018","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"5878_CR24","doi-asserted-by":"publisher","unstructured":"Obeid, M. A., Alyamani, H., Amawi, H., Aljabali, A. A. A., Rezigue, M., Abdeljaber, S. N., & Ferro, V. A. (2021). siRNA Delivery to Melanoma Cells with Cationic Niosomes. In Methods in Molecular Biology, 2265, 621-634. https:\/\/doi.org\/10.1007\/978-1-0716-1205-7_42","DOI":"10.1007\/978-1-0716-1205-7_42"},{"key":"5878_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120105","author":"I Ziv","year":"1997","unstructured":"Ziv, I., Zilkha-Falb, R., Offen, D., Shirvan, A., Barzilai, A., & Melamed, E. (1997). Levodopa induces apoptosis in cultured neuronal cells - A possible accelerator of nigrostriatal degeneration in Parkinson\u2019s disease? Movement Disorders, 12(1), 17-23. https:\/\/doi.org\/10.1002\/mds.870120105","journal-title":"Movement Disorders"},{"key":"5878_CR26","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.50.6_suppl_6.s39","author":"PG Jenner","year":"1998","unstructured":"Jenner, P. G., & Brin, M. F. (1998). Levodopa neurotoxicity: Experimental studies versus clinical relevance. Neurology, 50(6_suppl_6), S39-S43. https:\/\/doi.org\/10.1212\/wnl.50.6_suppl_6.s39","journal-title":"Neurology"},{"key":"5878_CR27","doi-asserted-by":"publisher","unstructured":"K\u00fc\u00e7\u00fckdo\u011fru, R., T\u00fcrkez, H., Arslan, M. E., Tozlu, \u00d6. \u00d6., S\u00f6nmez, E., Mardino\u011flu,A., \u2026 Di Stefano, A. (2020). Neuroprotective effects of boron nitride nanoparticles in the experimental Parkinson\u2019s disease model against MPP+ induced apoptosis. Metabolic Brain Disease, 35(6), 947\u2013957. https:\/\/doi.org\/10.1007\/s11011-020-00559-6","DOI":"10.1007\/s11011-020-00559-6"},{"key":"5878_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2008.11.001","author":"YT Cheung","year":"2009","unstructured":"Cheung, Y. T., Lau, W. K. W., Yu, M. S., Lai, C. S. W., Yeung, S. C., So, K. F., & Chang, R. C. C. (2009). Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research. NeuroToxicology, 30(1), 127-135. https:\/\/doi.org\/10.1016\/j.neuro.2008.11.001","journal-title":"NeuroToxicology"},{"key":"5878_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2004.05.075","author":"A J\u00e4ms\u00e4","year":"2004","unstructured":"J\u00e4ms\u00e4, A., Hasslund, K., Cowburn, R. F., B\u00e4ckstr\u00f6m, A., & Vas\u00e4nge, M. (2004). The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer\u2019s disease-like tau phosphorylation. Biochemical and Biophysical Research Communications, 319(3), 993-1000. https:\/\/doi.org\/10.1016\/j.bbrc.2004.05.075","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"5878_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0063862","author":"JA Korecka","year":"2013","unstructured":"Korecka, J. A., van Kesteren, R. E., Blaas, E., Spitzer, S. O., Kamstra, J. H., Smit, A. B., & Bossers, K. (2013). Phenotypic Characterization of Retinoic Acid Differentiated SH-SY5Y Cells by Transcriptional Profiling. Plos One, 8(5), e63862. https:\/\/doi.org\/10.1371\/journal.pone.0063862","journal-title":"Plos One"},{"key":"5878_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(02)00216-2","author":"JPM Finberg","year":"2002","unstructured":"Finberg, J. P. M., & Youdim, M. B. H. (2002). Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours. Neuropharmacology, 43(7), 1110-1118. https:\/\/doi.org\/10.1016\/S0028-3908(02)00216-2","journal-title":"Neuropharmacology"},{"key":"5878_CR32","unstructured":"Pavlov, A. N., Pyatigorskaya, N. V., Brkich, G. E., Shabalina, M. M., & Beregovykh, V. V. (2018). Study of adhesive properties of new dosage forms for Nano-L-DOPA nasal delivery system based on PLGA nanoparticles. Journal of Pharmaceutical Sciences and Research, 10(3), 668-671"},{"key":"5878_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2016.03.012","author":"LJ Spielman","year":"2016","unstructured":"Spielman, L. J., Little, J. P., & Klegeris, A. (2016). Physical activity and exercise attenuate neuroinflammation in neurological diseases. Brain Research Bulletin, 125, 19-29. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.03.012","journal-title":"Brain Research Bulletin"},{"key":"5878_CR34","doi-asserted-by":"publisher","DOI":"10.2174\/1570159x16666180222165418","author":"Q Rui","year":"2018","unstructured":"Rui, Q., Ni, H., Li, D., Gao, R., & Chen, G. (2018). The Role of LRRK2 in Neurodegeneration of Parkinson Disease. Current Neuropharmacology, 16(9), 1348\u20131357. https:\/\/doi.org\/10.2174\/1570159x16666180222165418","journal-title":"Current Neuropharmacology"},{"key":"5878_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-020-01062-w","author":"PMJ Quinn","year":"2020","unstructured":"Quinn, P. M. J., Moreira, P. I., Ambr\u00f3sio, A. F., & Alves, C. H. (2020). PINK1\/PARKIN signalling in neurodegeneration and neuroinflammation. Acta neuropathologica communications, 8(1), 189. https:\/\/doi.org\/10.1186\/s40478-020-01062-w","journal-title":"Acta neuropathologica communications"},{"key":"5878_CR36","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.biortech.2018.03.001","volume":"258","author":"Z Dai","year":"2018","unstructured":"Dai, Z., Zhou, H., Zhang, S., Gu, H., Yang, Q., Zhang, W., & Xin, F. (2018). Current advance in biological production of malic acid using wild type and metabolic engineered strains. Bioresource Technology, 258, 345\u2013353. https:\/\/doi.org\/10.1016\/j.biortech.2018.03.001","journal-title":"Bioresource Technology"},{"key":"5878_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.655819","author":"L Yao","year":"2021","unstructured":"Yao, L., Wu, J., Koc, S., & Lu, G. (2021). Genetic Imaging of Neuroinflammation in Parkinson\u2019s Disease: Recent Advancements. Frontiers in Cell and Developmental Biology, 15(9), 655819. https:\/\/doi.org\/10.3389\/fcell.2021.655819","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"5878_CR38","doi-asserted-by":"publisher","unstructured":"Patil, A. C., Patil, A. S., Desai, S. P., Phalke, T. M., & Saralaya, M. G. (2022). Niosomes: A Future Of Targeted Drug Delivery Systems As Promising Nanocarrier Through Blood-Brain Barrier For Natural Drug Delivery. NeuroQuantology, 20(17), 1547-1554. https:\/\/doi.org\/10.48047\/NQ.2022.20.17.NQ880192","DOI":"10.48047\/NQ.2022.20.17.NQ880192"},{"key":"5878_CR39","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2013.790887","author":"CV Pardeshi","year":"2013","unstructured":"Pardeshi, C. V., & Belgamwar, V. S. (2013). Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: An excellent platform for brain targeting. Expert Opinion on Drug Delivery, 10(7), 957-972. https:\/\/doi.org\/10.1517\/17425247.2013.790887","journal-title":"Expert Opinion on Drug Delivery"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05878-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05878-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-026-05878-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:16:53Z","timestamp":1792077413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-026-05878-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["5878"],"URL":"https:\/\/doi.org\/10.1007\/s12010-026-05878-5","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]},"assertion":[{"value":"10 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study did not involve human participants or animals. Therefore, ethical approval was not required.","order":1,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}